These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19823588)

  • 1. Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins.
    Shortridge MD; Powers R
    PLoS One; 2009 Oct; 4(10):e7442. PubMed ID: 19823588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system.
    Rathinavelan T; Lara-Tejero M; Lefebre M; Chatterjee S; McShan AC; Guo DC; Tang C; Galan JE; De Guzman RN
    J Mol Biol; 2014 Aug; 426(16):2958-69. PubMed ID: 24951833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the electrostatic surfaces of the type III secretion needle proteins PrgI, BsaL, and MxiH.
    Wang Y; Ouellette AN; Egan CW; Rathinavelan T; Im W; De Guzman RN
    J Mol Biol; 2007 Aug; 371(5):1304-14. PubMed ID: 17617421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of PrgI-SipD: insight into a secretion competent state of the type three secretion system needle tip and its interaction with host ligands.
    Lunelli M; Hurwitz R; Lambers J; Kolbe M
    PLoS Pathog; 2011 Aug; 7(8):e1002163. PubMed ID: 21829362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction between the Salmonella type III secretion system tip protein SipD and the needle protein PrgI by paramagnetic relaxation enhancement.
    Rathinavelan T; Tang C; De Guzman RN
    J Biol Chem; 2011 Feb; 286(6):4922-30. PubMed ID: 21138848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common structural architecture of Shigella flexneri and Salmonella typhimurium type three secretion needles.
    Demers JP; Sgourakis NG; Gupta R; Loquet A; Giller K; Riedel D; Laube B; Kolbe M; Baker D; Becker S; Lange A
    PLoS Pathog; 2013 Mar; 9(3):e1003245. PubMed ID: 23555258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and localization of the Salmonella SPI-1 type III secretion needle complex proteins PrgI and PrgJ.
    Sukhan A; Kubori T; Galán JE
    J Bacteriol; 2003 Jun; 185(11):3480-3. PubMed ID: 12754250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
    Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
    Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characterization of MxiH and PrgI, the needle component of the type III secretion apparatus from Shigella and Salmonella.
    Darboe N; Kenjale R; Picking WL; Picking WD; Middaugh CR
    Protein Sci; 2006 Mar; 15(3):543-52. PubMed ID: 16501225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein secreted by the
    Kato J; Dey S; Soto JE; Butan C; Wilkinson MC; De Guzman RN; Galan JE
    Elife; 2018 Jul; 7():. PubMed ID: 30015613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
    Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
    Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
    J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical Bcl-2 motifs of the Na+/K+ pump revealed by the BH3 mimetic chelerythrine: early signal transducers of apoptosis?
    Lauf PK; Heiny J; Meller J; Lepera MA; Koikov L; Alter GM; Brown TL; Adragna NC
    Cell Physiol Biochem; 2013; 31(2-3):257-76. PubMed ID: 23466888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
    Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
    J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and engineering of the type 3 secretion system needle monomer from
    Burdette LA; Leach SA; Kennedy N; Ikwuagwu BC; Summers JS; Tullman-Ercek D
    mSphere; 2024 Aug; 9(8):e0036724. PubMed ID: 39109886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
    Kelekar A; Chang BS; Harlan JE; Fesik SW; Thompson CB
    Mol Cell Biol; 1997 Dec; 17(12):7040-6. PubMed ID: 9372935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAST-NMR: functional annotation screening technology using NMR spectroscopy.
    Mercier KA; Baran M; Ramanathan V; Revesz P; Xiao R; Montelione GT; Powers R
    J Am Chem Soc; 2006 Nov; 128(47):15292-9. PubMed ID: 17117882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1.
    Feng W; Huang S; Wu H; Zhang M
    J Mol Biol; 2007 Sep; 372(1):223-35. PubMed ID: 17659302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.